Health values of the seriously ill

Annals of Internal Medicine

Volumn 122, Issue 7, 1995, Pages 514-520

  Tsevat, Joel ^a   Cook, E Francis ^b   Green, Michael L ^c   Matchar, David B ^d   Dawson, Neal V ^e   Broste, Steven K ^f   Wu, Albert W ^g   Phillips, Russell S ^c   Oye, Robert K ^h   Goldman, Lee ⁱ  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

^f MARSHFIELD CLINIC   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DECISION MAKING; FEMALE; HUMAN; HUMAN TISSUE; MALE; MORTALITY; MULTICENTER STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; SURVIVAL TIME; WELLBEING;

EID: 0028965681     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-122-7-199504010-00007     Document Type: Article

References (64)

1. U.S. Congress. Omnibus Budget Reconciliation Act of 1990. Pub L no. 101-508.
2. Emanuel LL, Barry MJ, Emanuel EJ, Stoeckle JD. Advance directives: can patients' stated treatment choices be used to infer unstated choices? Med Care. 1994:32;95-105.
3. Murphy DJ, Matchar DB. Life-sustaining therapy. A model for appropriate use. JAMA. 1990;264:2103-8.
4. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7:118-33.
5. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
6. Tsevat J, Weeks JC, Guadagnoli E, Tosteson AN, Mangione CM, Pliskin JS, et al. Using health-related quality of life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med. 1994;9:576-82.
7. Kassirer JP. Incorporating patients' preferences into medical decisions [Editorial]. N Engl J Med. 1994;330:1895-6.
8. Murphy DJ, Cluff LE. The SUPPORT study. Introduction. J Clin Epidemiol. 1990;43(Suppl):v-x.
9. Kreling BK, Robinson DK, Bergner M. Data collection strategies in SUPPORT. J Clin Epidemiol. 1990;43(Suppl):5S-9S.
10. Murphy DJ, Knaus WA, Lynn J. Study population in SUPPORT: patients (as defined by disease categories and mortality projections), surrogates, and physicians. J Clin Epidemiol. 1990;43(Suppl):11S-28S.
11. Phillips RS, Knaus WA. Patient characteristics in SUPPORT: sociodemographics, admission diagnosis, co-morbidities and acute physiology score. J Clin Epidemiol. 1990;43(Suppl):29S-31S.
12. Phillips RS, Goldman L, Bergner M. Patient characteristics in SUPPORT: activity status and cognitive function. J Clin Epidemiol. 1990; 43(Suppl):33S-36S.
13. Landefeld CS, Phillips RS, Bergner M. Patient characteristics in SUPPORT: functional status. J Clin Epidemiol. 1990;43(Suppl):37S-39S.
14. Phillips RS, Murphy DJ, Goldman L, Knaus WA. Patient characteristics in SUPPORT: disease specific clinical data. J Clin Epidemiol. 1990;43(Suppl):41S-45S.
15. Coulton CJ. Decision making in SUPPORT: patient perceptions and preferences. J Clin Epidemiol. 1990;43(Suppl):51S-54S.
16. Phillips RS, Rempusheski VF, Puopolo AL, Naccarato M, Mallatratt L. Decision making in SUPPORT: the role of the nurse. J Clin Epidemiol. 1990;43(Suppl):55S-58S.
17. Connors AF Jr, Dawson NV, Arkes HR, Roach MJ. Decision making in SUPPORT: physician perceptions and preferences. J Clin Epidemiol. 1990;43(Suppl):59S-62S.
18. Tsevat J, Dawson NV, Matchar DB. Assessing quality of life and preferences in the seriously ill using utility theory. J Clin Epidemiol. 1990;43(Suppl):73S-77S.
19. Desbiens NA, Broste SK, Layde PM. Collaborating hospital characteristics and their health-care and legal environments in SUPPORT. J Clin Epidemiol. 1990;43(Suppl):79S-81S.
20. Oye RK, Landefeld CS, Jayes RL. Outcomes in SUPPORT. J Clin Epidemiol. 1990;43(Suppl):83S-87S.
21. Harrell FE Jr, Marcus SE, Layde PM, Broste SK, Cook EF, Wagner DP, et al. Statistical methods in SUPPORT. J Clin Epidemiol. 1990; 43(Suppl):89S-98S.
22. Appendices. J Clin Epidemiol. 1990;43(Suppl):109S-123S.
23. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991; 100:1619-36.
24. Tsevat J, Goldman L, Lamas GA, Pfeffer MA, Chapin CC, Connors KF, et al. Functional status versus utilities in survivors of myocardial infarction. Med Care. 1991;29:1153-9.
25. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standard measure of biological and psychosocial function. JAMA. 1963;185:914-9.
26. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6:493-508.
27. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989; 64:651-4.
28. Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305-6.
29. McNair DM, Lorr M, Droppleman LF. EITS Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1971.
30. Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR. The sickness impact profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv. 1976;6:393-415.
31. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
32. Covinsky KE, Goldman L, Cook EF, Oye R, Desbiens N, Reding D et al. for the SUPPORT Investigators. The impact of serious illness on patients' families. JAMA. 1994;272:1839-44.
33. Tsevat J, Goldman L, Soukup JR, Lamas GA, Connors KF, Chapin CC, et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med Decis Making. 1993;13:161-5.
34. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Canadian Erythropoietin Study Group. BMJ. 1990;300:573-8.
35. Tsevat J, Solzan JG, Tolan KK, Soukup JR, Cook EF, Tosteson AN, et al. Health status and utilities of HIV+ and primary care patients [Abstract]. Clin Res. 1992;40:569A.
36. Churchill DN, Torrance GW, Taylor DW, Barnes CC, Ludwin D, Shimizu A, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med. 1987;10:14-20.
37. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effects on a costeffectiveness analysis. J Clin Epidemiol. 1992;45:505-12.
38. Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med. 1986;81:565-78.
39. Llewellyn-Thomas HA, Sutherland HJ, Tritchler DL, Lockwood GA, Till JE, Ciampi A, et al. Benign and malignant breast disease: the relationship between women's health status and health values. Med Decis Making. 1991;11:180-8.
40. Llewellyn-Thomas HA, Thiel EC, McGreal MJ. Cancer patients' evaluations of their current health states: the influences of expectations, comparisons, actual health status, and mood. Med Decis Making. 1992;12:115-22.
41. Revicki DA. Relationship between health utility and psychometric health status measures. Med Care. 1992;30(Suppl):MS274-82.
42. Llewellyn-Thomas HA, Sutherland HJ, Ciampi A, Etezadi-Amoli J, Boyd NF, Till JE. The assessment of values in laryngeal cancer: reliability of measurement methods. J Chronic Dis. 1984;37:283-91.
43. O'Connor AM, Boyd NF, Warde P, Stolbach L, Till JE. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis. 1987;40:811-8.
44. Llewellyn-Thomas HA, Sutherland HJ, Thiel EC. Do patients' evaluations of a future health state change when they actually enter that state? Med Care. 1993;31:1002-12.
45. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5:559-75.
46. Williams A, Is the QALY a technical solution to a political problem? Of course not! [Comment]. Int J Health Serv. 1991;21:365-9.
47. Kaplan RM. Value judgment in the Oregon Medicaid experiment. Med Care. 1994;32:975-88.
48. Kolata G. Ethicists struggle to judge the 'value' of life. The New York Times. 1992;Nov 24:C3.
49. La Puma J, Lawlor EF. Quality-adjusted life-years. Ethical implications for physicians and policymakers. JAMA. 1990;263:2917-21.
50. Carr-Hill RA. Allocating resources to health care: is the QALY (Quality Adjusted Life Year) a technical solution to a political problem? Int J Health Serv. 1991;21:351-63.
51. Carr-Hill RA. A response to Alan Williams. Int J Health Serv. 1991; 21:371-2.
52. Hadorn DC. Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAMA. 1991;265:2218-25.
53. Patrick DL, Bush JW, Chen MM. Methods for measuring levels of well-being for a health status index. Health Serv Res. 1973;8:228-45.
54. Carter WB, Bobbitt RA, Bergner M, Gilson BS. Validation of an interval scaling: the sickness impact profile. Health Serv Res. 1976;11: 516-28.
55. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31:697-704.
56. Rosser R, Kind P. A scale of evaluations of states of illness: is there a social consensus? Int J Epidemiol. 1979;7:347-58.
57. Wolfson AD, Sinclair AJ, Bombardier C, McGeer A.Preference measurements for functional status in stroke patients: interrater and intertechnique comparisons. In: Kane RL, Kane RA, eds. Values and Long-Term Care. Toronto: D.C. Heath; 1982:191-214.
58. Boyd NF, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ. Whose utilities for decision analysis? Med Decis Making. 1990;10:58-67.
59. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Operations Research. 1980;28:206-24.
60. Miyamoto JM, Eraker SA. Parameter estimates for a QALY utility model. Med Decis Making. 1985;5:191-213.
61. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981;305:982-7.
62. Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989;9:142-9.
63. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, et al. The Beaver Dam Health Outcomes Study: initial catalog of healthstate quality factors. Med Decis Making. 1993;13:89-102.
64. Eddy DM. Oregon's methods: did cost-effectiveness analysis fail? JAMA. 1991;266:2135-41.